CN110959708A - 一种降糖茶及其制备方法 - Google Patents
一种降糖茶及其制备方法 Download PDFInfo
- Publication number
- CN110959708A CN110959708A CN201911275249.2A CN201911275249A CN110959708A CN 110959708 A CN110959708 A CN 110959708A CN 201911275249 A CN201911275249 A CN 201911275249A CN 110959708 A CN110959708 A CN 110959708A
- Authority
- CN
- China
- Prior art keywords
- tea
- parts
- guava
- blood sugar
- decocting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 32
- 210000004369 blood Anatomy 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 241001122767 Theaceae Species 0.000 title description 19
- 235000013616 tea Nutrition 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 29
- 241000508269 Psidium Species 0.000 claims abstract description 20
- 235000020334 white tea Nutrition 0.000 claims abstract description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 244000302512 Momordica charantia Species 0.000 claims abstract description 13
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 12
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 12
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 12
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 12
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 12
- 235000011477 liquorice Nutrition 0.000 claims abstract description 12
- 229940013618 stevioside Drugs 0.000 claims abstract description 12
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019202 steviosides Nutrition 0.000 claims abstract description 12
- 241000233779 Cyclocarya paliurus Species 0.000 claims abstract description 11
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 10
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 5
- 244000269722 Thea sinensis Species 0.000 claims abstract 9
- 239000008187 granular material Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000007779 soft material Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 230000035922 thirst Effects 0.000 abstract description 19
- 235000019640 taste Nutrition 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 238000010791 quenching Methods 0.000 abstract description 14
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 12
- 230000000171 quenching effect Effects 0.000 abstract description 11
- 210000001124 body fluid Anatomy 0.000 abstract description 8
- 239000010839 body fluid Substances 0.000 abstract description 8
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 6
- 206010020710 Hyperphagia Diseases 0.000 abstract description 4
- 208000006083 Hypokinesia Diseases 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 206010036067 polydipsia Diseases 0.000 abstract description 4
- 208000022530 polyphagia Diseases 0.000 abstract description 4
- 230000003867 tiredness Effects 0.000 abstract description 4
- 208000016255 tiredness Diseases 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000035622 drinking Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 description 23
- 229940079593 drug Drugs 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 9
- 230000007935 neutral effect Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 241000675108 Citrus tangerina Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 208000025174 PANDAS Diseases 0.000 description 1
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种降糖茶及其制备方法，涉及保健茶领域，其中降糖茶包括如下重量份原料：老白茶11.5‑12.5份、青钱柳7.5‑8.5份、番石榴1.1‑1.25份、葛根1.1‑1.25份、山药0.7‑0.85份、黄精0.55‑0.65份、苦瓜0.55‑0.65份、乌梅0.15‑0.25份、陈皮0.35‑0.45份、甘草0.45‑0.55份、甜叶菊甙0.09‑0.15份。本发明提供了一种降糖茶，采用多种常见中药制成，各味中药相互影响，相互协同，相辅相成，具有益气养阴、清热、解毒、生津止渴的显著功效，有助于减轻I‑II型糖尿病患者口渴喜饮，体倦乏力，多食多饮多尿等的症状，并且药性温和无副作用，口味丰富，饮用方便，价格低廉，是糖尿病患者日常理想的辅助性衡糖茶饮料。
Description
技术领域
本发明涉及保健茶领域，尤其是一种降糖茶及其制备方法。
背景技术
糖尿病是世界范围内最常见的内分泌性疾病之一，是继肿瘤、血管病变之后第三大严重威胁人类健康的慢性非传染性疾病，具有高致死率、高致残率和高医疗负担的特征，成为当前世界各国共同面对的公共健康问题。I-II型糖尿病患者的临床表现普遍具有三多一少症状，即多尿、多饮、多食和消瘦症状。
但是由于糖尿病患者必须严格控制糖分的摄入，因此只能长期饮用无糖成分的茶水来缓解口渴喜饮的症状，为此，人们开始致力于开发一种健康无糖、口味丰富、配伍简单、饮用方便、能够辅助降糖且副作用小的中药保健茶。但是目前市场上针对于糖尿病患者的保健茶大多存在配方组分不合理，生产工艺繁琐，质量不好控制、药效单一且成本较高等的问题。
发明内容
本发明提供一种降糖茶及其制备方法，其主要目的在于解决现有降血糖的保健茶大多存在配方组分不合理，生产工艺繁琐，质量不好控制、药效单一且成本较高等的问题。
本发明采用如下技术方案：
一种降糖茶，包括如下重量份原料：老白茶11.5-12.5份、青钱柳7.5-8.5份、番石榴1.1-1.25份、葛根1.1-1.25份、山药0.7-0.85份、黄精0.55-0.65份、苦瓜0.55-0.65份、乌梅0.15-0.25份、陈皮0.35-0.45份、甘草0.45-0.55份、甜叶菊甙0.09-0.15份。
进一步，上述番石榴为新鲜番石榴全果去蒂切薄片干燥后而得到的番石榴果干。
一种如上所述的降糖茶的制备方法包括如下步骤：
（1）预处理：对以上各原料进行挑拣选剔处理.
（2）粉粹：按预定成分称取老白茶和青钱柳两种原料，经多功能粉碎机或变频粉碎机粉碎成细末，并放于塑料桶密闭收存待用。
（3）煎煮：按预定成分称取番石榴、葛根、山药、黄精、苦瓜、乌梅、陈皮、甘草和甜叶菊甙放于不锈钢锅内，加水浸过药面使其充分浸泡，然后用直火加热煎煮至沸腾，改用文火煎煮1.5小时后过滤；将滤渣重复加水煎煮至沸腾，改用文火煎煮1小时后过滤；最后将两次滤液合并加热浓缩，并冷却备用。
（4）制粒：将粉粹后的细末放于槽式混合机中，倒入冷却后的浓缩液搅拌30分钟制成软材，再用摇摆式颗粒机进行制粒。
（5）烘干：将湿颗粒摊盘放于烘箱中进行烘干，控制温度在65℃以内，烘干2-4小时后取出放凉冷却。
（6）分装：将冷却后的颗粒用颗粒分装机按规定标准包装量进行分装处理。
进一步，步骤（4）中软材用摇摆式颗粒机过14目筛制作成颗粒。
根据本发明中各成分的功效和相互作用的机理，可将其分为君药、臣药、佐药和使药四大类，其中君药包括老白茶、青钱柳和番石榴，臣药包括葛根、山药和黄精，佐药包括苦瓜、乌梅和陈皮，使药包括甘草和甜叶菊甙。根据《本草纲目》、《中药大辞典》等药学名著以及现代医学研究显示：
老白茶：即贮存多年的白茶，味苦甘、性微温。白茶经过陈放之后，其多酚类物质不断的氧化，转化为更高含量的黄酮、茶氨酸和咖啡碱等成分。黄酮具有降血脂、降血压、降血糖、抗疲劳、抗病毒、利尿等功效。并且国内外医学研究证明，长期饮用老白茶可以显著提高人体内脂酶活性，促进脂肪分解代谢，有效控制胰岛素分泌量，延缓葡萄糖的肠吸收，分解体内血液中多余的糖份，促进血糖平衡。
青钱柳：味辛，性平。青钱柳被誉为植物界的大熊猫，医学界的第三棵树，其富含丰富的皂苷、黄酮、多糖等有机营养成分，能够有效平衡人体糖代谢，从而达到降血糖，逆转并发症的养生效果；此外还含有大量的糖代谢和胰岛素作用密切相关的Ni、Cr、V、Se等元素的含量较高，能够协助胰岛素发挥降血糖作用，并能改善糖耐量。
番石榴：味甘、涩，性平。番石榴营养丰富，富含维生素C，并含有磷、钙、镁等微量元素，具有治疗糖尿病及降血糖的药效，并有防治高血压、防老化、抗氧化作用、健胃消食、助消化的功效。
葛根：味甘、辛，性凉，主阳明。葛根素有“亚洲人参”之美誉，有清火、排毒、热病口渴，阴虚消渴，降血脂、降血压、降胆固醇、降血糖、减肥、通便、预防老年性痴呆、防止动脉硬化、防止脑血栓等心脑血管疾病之良效。
山药：味甘，性平，归脾、肺、肾经，补脾养胃，生津益肺，补肾涩精。临床多用于脾虚食少，久泻不止，肺虚喘咳，肾虚遗精，带下，尿频，虚热消渴。现代医学研究表明山药可以显著降低糖尿病大鼠的血糖水平和糖化血红蛋白率，并使胰岛素分泌水平具有明显的恢复性升高。
黄精：采用九制黄精，味甘，性平，归肺，脾，肾经，补气养阴，健脾，润肺，益肾，用于脾胃气虚，体倦乏力，胃阴不足，口干食少，肺虚燥咳，劳嗽咳血，精血不足，腰膝酸软，须发早白，内热消渴。现代医学研究表明黄精对肾上腺素引起的血糖过高呈显著抑制作用。
苦瓜：味苦，性寒，归心、胃、肝经，具有清热、除烦、止渴、明目功效，临床多用于中暑发热，牙痛，泄泻，痢疾，便血等。现代医学研究表明苦瓜对于糖尿病有一定的辅助治疗作用，对于处方药带来的副作用有一定的缓解、对糖尿病并发症有很好的预防和治疗作用。
乌梅：味酸、涩，性平，归肝、脾、肺、大肠经，具有敛肺止咳，涩肠止泻，安蛔止痛，生津止渴等功效。主治肺虚久咳，久泻，久痢，蛔厥腹痛，呕吐，虚热消渴。味酸性平的乌梅，能酸甘化阴、生津止渴。
陈皮：味辛、苦，性温，入脾经、胃经、肺经，现代医学研究表明，陈皮有三大类作用，一是导胸中寒邪，二破滞气，三益脾胃。这三大作用中，主要作用是行脾胃之气。脾胃主运化水湿，故脾胃之气行则能去湿、健脾、化痰，故又可以说，陈皮温能养脾，辛能醒脾，苦能健脾。
甘草：味甘，性平，入脾、胃、肺经， 常用于和中缓急，润肺，解毒，调和渚药。
甜叶菊甙：甜叶菊甙为菊科植物甜叶的菊叶或蔷薇科植物甜菜叶，具有降糖、强壮、降血压等作用，可作为甜味剂使用。
全方以味辛，性平，具清热、解毒、治消渴的青钱柳；苦甘，微温，消积利尿、降三脂、促血糖平衡、补脾益肺、生津止渴及抑血糖的老白茶；味甘、涩，性平的番石榴为君药。臣以性凉，味甘、辛，主阳明，具清火排毒、健脾升阳、生津止渴的葛根；味甘、性平，滋精固肾、益气养阴、生津止渴、固敛阴津的山药；味甘、性平，补脾益阴、生精填髓、以健脾消积、涩肠止泻，降血糖的黄精。佐以苦寒，具除邪热、解劳乏、清心明目，隐血糖 益气壮阳的苦瓜；味酸性平，能酸甘化阴、生津止渴的乌梅；味辛、苦，性温，能健脾行气、条畅气机，可使全方补而不滞，滋而不腻的橘。并以养阴生津的糖尿病患者植物甜味剂甜叶菊甙及味甘、益气补脾、调和诸药的甘草为使药，从而使全方达到益气养阴、清热、解毒，生津止渴的显著功效，适用于气阴两虚所致的消渴病日常饮品，是证见口渴喜饮，体倦乏力，多食多饮多尿等I-II型糖尿病患者的日常理想的辅助性衡糖茶饮料。
综上所述，和现有技术相比，本发明产生的有益效果在于：
本发明提供了一种降糖茶，采用多种常见中药制成，各味中药相互影响，相互协同，相辅相成，具有益气养阴、清热、解毒、生津止渴的显著功效，有助于减轻I-II型糖尿病患者口渴喜饮，体倦乏力，多食多饮多尿等的症状，并且药性温和无副作用，口味丰富，饮用方便，价格低廉，是糖尿病患者日常理想的辅助性衡糖茶饮料。
具体实施方式
下面说明本发明的具体实施方式。为了全面理解本发明，下面描述到许多细节，但对于本领域技术人员来说，无需这些细节也可实现本发明。
一种降糖茶，包括如下重量份原料：老白茶12份、青钱柳8份、番石榴1.2份、葛根1.2份、山药0.8份、黄精0.6份、苦瓜0.6份、乌梅0.2份、陈皮0.4份、甘草0.5份、甜叶菊甙0.1份。
上述降糖茶的制备方法包括如下步骤：
（1）预处理：对以上各原料进行挑拣选剔处理。
（2）粉粹：按预定成分称取老白茶和青钱柳两种原料，经多功能粉碎机或变频粉碎机粉碎成细末，并放于塑料桶密闭收存待用。
（3）煎煮：按预定成分称取番石榴、葛根、山药、黄精、苦瓜、乌梅、陈皮、甘草和甜叶菊甙放于不锈钢锅内，加水浸过药面使其充分浸泡，然后用直火加热煎煮至沸腾，改用文火煎煮1.5小时后过滤；将滤渣重复加水煎煮至沸腾，改用文火煎煮1小时后过滤；最后将两次滤液合并加热浓缩，并冷却备用。
（4）制粒：将粉粹后的细末放于槽式混合机中，倒入冷却后的浓缩液搅拌30分钟制成软材，再用摇摆式颗粒机进行制粒，从而将软材过14目筛制作成颗粒。
（5）烘干：将湿颗粒摊盘放于烘箱中进行烘干，控制温度在65℃以内，烘干2-4小时后取出放凉冷却。
（6）分装：将冷却后的颗粒用颗粒分装机按规定标准包装量进行分装处理。
分装前检测降糖茶颗粒的含水量＜8%，灰分＜8%，经反复试验得知，该降糖茶具有益气养阴、清热、解毒，生津止渴的显著疗效，并且药性温和无副作用，口味丰富，饮用方便，价格低廉，是糖尿病患者日常理想的辅助性衡糖茶饮料。
上述仅为本发明的具体实施方式，但本发明的设计构思并不局限于此，凡利用此构思对本发明进行非实质性的改动，均应属于侵犯本发明保护范围的行为。
Claims (4)
1.一种降糖茶，其特征在于：包括如下重量份原料：老白茶11.5-12.5份、青钱柳7.5-8.5份、番石榴1.1-1.25份、葛根1.1-1.25份、山药0.7-0.85份、黄精0.55-0.65份、苦瓜0.55-0.65份、乌梅0.15-0.25份、陈皮0.35-0.45份、甘草0.45-0.55份、甜叶菊甙0.09-0.15份。
2.如权利要求1所述的一种降糖茶，其特征在于：所述番石榴为新鲜番石榴全果去蒂切薄片干燥后而得到的番石榴果干。
3.一种如权利要求1所述的降糖茶的制备方法，其特征在于：包括如下步骤：
（1）预处理：对以上各原料进行挑拣选剔处理；
（2）粉粹：按预定成分称取老白茶和青钱柳两种原料，经多功能粉碎机或变频粉碎机粉碎成细末，并放于塑料桶密闭收存待用；
（3）煎煮：按预定成分称取番石榴、葛根、山药、黄精、苦瓜、乌梅、陈皮、甘草和甜叶菊甙放于不锈钢锅内，加水浸过药面使其充分浸泡，然后用直火加热煎煮至沸腾，改用文火煎煮1.5小时后过滤；将滤渣重复加水煎煮至沸腾，改用文火煎煮1小时后过滤；最后将两次滤液合并加热浓缩，并冷却备用；
（4）制粒：将粉粹后的细末放于槽式混合机中，倒入冷却后的浓缩液搅拌30分钟制成软材，再用摇摆式颗粒机进行制粒；
（5）烘干：将湿颗粒摊盘放于烘箱中进行烘干，控制温度在65℃以内，烘干2-4小时后取出放凉冷却；
（6）分装：将冷却后的颗粒用颗粒分装机按规定标准包装量进行分装处理。
4.如权利要求3所述的降糖茶的制备方法，其特征在于：步骤（4）中软材用摇摆式颗粒机过14目筛制作成颗粒。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911275249.2A CN110959708A (zh) | 2019-12-12 | 2019-12-12 | 一种降糖茶及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911275249.2A CN110959708A (zh) | 2019-12-12 | 2019-12-12 | 一种降糖茶及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110959708A true CN110959708A (zh) | 2020-04-07 |
Family
ID=70033944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911275249.2A Pending CN110959708A (zh) | 2019-12-12 | 2019-12-12 | 一种降糖茶及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110959708A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112136998A (zh) * | 2020-09-02 | 2020-12-29 | 岳康医疗生物科技有限公司 | 辅助降血脂改善血液循环的固体饮料配方及其制备方法 |
| CN115211482A (zh) * | 2022-09-06 | 2022-10-21 | 广州市致仁医药科技有限公司 | 一种清热助消止渴茶及其制备方法 |
| CN118661792A (zh) * | 2024-08-22 | 2024-09-20 | 福建南安市莲花峰茶厂 | 降糖茶及其制备方法 |
| CN118661792B (zh) * | 2024-08-22 | 2024-11-08 | 福建南安市莲花峰茶厂 | 降糖茶及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050118324A1 (en) * | 2003-12-02 | 2005-06-02 | Mathew Anna M. | Good living tea - a diabetic dietary supplement drink |
| CN102754710A (zh) * | 2012-06-07 | 2012-10-31 | 王宇 | 降糖茶 |
| CN104288501A (zh) * | 2014-06-30 | 2015-01-21 | 广西健丰药业有限公司 | 一种降糖颗粒及其制备方法 |
| CN104686725A (zh) * | 2015-03-31 | 2015-06-10 | 吴绍平 | 一种青钱柳养生茶及其制备方法 |
-
2019
- 2019-12-12 CN CN201911275249.2A patent/CN110959708A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050118324A1 (en) * | 2003-12-02 | 2005-06-02 | Mathew Anna M. | Good living tea - a diabetic dietary supplement drink |
| CN102754710A (zh) * | 2012-06-07 | 2012-10-31 | 王宇 | 降糖茶 |
| CN104288501A (zh) * | 2014-06-30 | 2015-01-21 | 广西健丰药业有限公司 | 一种降糖颗粒及其制备方法 |
| CN104686725A (zh) * | 2015-03-31 | 2015-06-10 | 吴绍平 | 一种青钱柳养生茶及其制备方法 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112136998A (zh) * | 2020-09-02 | 2020-12-29 | 岳康医疗生物科技有限公司 | 辅助降血脂改善血液循环的固体饮料配方及其制备方法 |
| CN115211482A (zh) * | 2022-09-06 | 2022-10-21 | 广州市致仁医药科技有限公司 | 一种清热助消止渴茶及其制备方法 |
| CN118661792A (zh) * | 2024-08-22 | 2024-09-20 | 福建南安市莲花峰茶厂 | 降糖茶及其制备方法 |
| CN118661792B (zh) * | 2024-08-22 | 2024-11-08 | 福建南安市莲花峰茶厂 | 降糖茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
| CN102669772B (zh) | 中草药益胃保健饮品 | |
| CN103431115B (zh) | 一种保健茶及其制备方法 | |
| CN110959708A (zh) | 一种降糖茶及其制备方法 | |
| CN103349121B (zh) | 降三高保健茶及其制备方法 | |
| KR102267801B1 (ko) | 쌍화차 조성물 및 그 제조방법 | |
| CN106666639A (zh) | 一种菊花药膳组合物及其制备方法 | |
| CN115645491A (zh) | 一种补益脾肺的中药组合物及其制备方法 | |
| CN104643205A (zh) | 一种枇杷保健饮料 | |
| CN115089661A (zh) | 辅助调节内分泌代谢并抗癌防癌的人参组合物的应用 | |
| CN106421491A (zh) | 一种山芝麻降血糖口服液的配方及制备方法 | |
| CN106234699A (zh) | 一种清热宣化治疗发热的药茶及制备加工方法 | |
| CN106173033A (zh) | 一种清热利尿治疗急性肾炎药茶及制备加工方法 | |
| CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
| CN104800600A (zh) | 一种治疗高血压的药物 | |
| CN114600988B (zh) | 一种养胃暖宫植物饮料 | |
| CN102224894B (zh) | 当归养生酒及其制备方法 | |
| CN106798044A (zh) | 一种党参补中益气果味茶膏及其制备方法 | |
| CN106165813A (zh) | 一种温中健胃治疗胃扭转药茶及制备加工方法 | |
| CN105767399A (zh) | 一种降三高护肝保健养生茶 | |
| CN106165745A (zh) | 一种益气滋肾养阴治疗血小板减少症的药茶及制备加工方法 | |
| CN113100367A (zh) | 一种基于中药的保健饮品及其制作方式 | |
| CN114947032A (zh) | 一种能够改善血液质量、促进营养平衡的固体饮料 | |
| CN116650592A (zh) | 一种用于软化血管、降血糖血压调节免疫的保健品及应用 | |
| CN113368225A (zh) | 一种用于治疗糖尿病和三高的复合方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200407 |